{
    "nct_id": "NCT04895709",
    "official_title": "A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors",
    "inclusion_criteria": "* Fresh pre-treatment and on-treatment tumor biopsy must be provided for biomarker analysis\n* Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 and at least 1 lesion accessible for biopsy. Fine needle biopsy, cytology, and bone lesion biopsies are not acceptable.\n* Eastern Cooperative Oncology Group Performance Status of 0 or 1\n* Radiographically documented progressive disease on or after the most recent therapy\n* Received standard-of-care therapies, (except for Part 1C, where participants with prior docetaxel use for the advanced/metastatic setting will be excluded), including an available programmed death (ligand)-1 inhibitor known to be effective in the tumor type for which they are being evaluated\n* Advanced or metastatic disease and have received, be refractory to, not be a candidate for, or be intolerant of existing therapies known to provide clinical benefit for the condition of the participant\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Women who are pregnant or breastfeeding\n* Primary central nervous system (CNS) malignancy\n* Untreated CNS metastases\n* Leptomeningeal metastases\n* Concurrent malignancy requiring treatment or history of prior malignancy active within 2 years prior to the first dose of study treatment\n* Active, known, or suspected autoimmune disease\n* Condition requiring systemic treatment with either corticosteroids within 14 days or other immunosuppressive medications within 30 days of the first dose of study treatment\n* Prior organ or tissue allograft\n* Uncontrolled or significant cardiovascular disease\n* Major surgery within 4 weeks of study drug administration\n* History of or with active interstitial lung disease or pulmonary fibrosis\n\nOther protocol-defined inclusion/exclusion criteria apply",
    "miscellaneous_criteria": ""
}